Sponsor Pipeline

Affidea Nu-med Center of Oncological DIagnostics and Therapy Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
5
Recruiting
2
Phase 3
4
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-22 NCT07426094
PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA…		 Enrollment reduced: 1600 -> 600 participants
2026-07-22 NCT07426055
PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged…		 Enrollment reduced: 1200 -> 1000 participants
Active Trials by Phase
Phase 2/3
2
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07426055 PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged… Prostate Cancer (Adenocarcinoma) Recruiting
NCT07426094 PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA… Prostate Cancer Recruiting
Not specified
NCT07667192 Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer Recurrent Gynecologic Cancer Recruiting
NCT07686016 Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic… Prostate Cancer Recruiting
NCT07691697 PSMA PET-Guided Progression-Directed Radiotherapy for Oligoprogressive Prostate Cancer Oligoprogressive Prostate Cancer Recruiting
Disease Areas
Prostate Cancer (4) Ovarian Cancer (1) Cervical Cancer (1) Endometrial Cancer (1)
Get alerts when Affidea Nu-med Center of Oncological DIagnostics and Therapy's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free